Cargando…

Efficacy of a 6-Week Home-Based Online Supervised Exercise Program Conducted During COVID-19 in Patients With Post Percutaneous Coronary Intervention: A Single-Blind Randomized Controlled Trial

OBJECTIVE: The aim of this study was to assess the efficacy of a 6-week cardiac rehabilitation (CR) program designed for patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI) that involved an online supervised exercise program that they could access during COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiajia, Liu, Bo, Wang, Zheng, El-Ansary, Doa, Adams, Roger, Han, Jia, Meng, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021490/ https://www.ncbi.nlm.nih.gov/pubmed/35463794 http://dx.doi.org/10.3389/fcvm.2022.853376

Ejemplares similares

Reliability and validity of sit-to-stand test protocols in patients with coronary artery disease
por: Wang, Zheng, et al.
Publicado: (2022)

Translation, Cultural Adaptation, Reliability, and Validity Testing of a Chinese Version of the Self-Administered Mediterranean Diet Scale
por: Li, Jiajia, et al.
Publicado: (2022)

Differential Evaluating Effect on Exercise Capacity of Cardiopulmonary Exercise Testing and Treadmill Exercise Testing in Post-percutaneous Coronary Intervention Patients
por: Gao, Yifan, et al.
Publicado: (2021)

Development and Validation of a Prediction Model for Cardiovascular Events in Exercise Assessment of Coronary Heart Disease Patients After Percutaneous Coronary Intervention
por: Shen, Tao, et al.
Publicado: (2022)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Temporal Trends in Complex Percutaneous Coronary Interventions
por: Kheifets, Mark, et al.
Publicado: (2022)

Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial
por: Hu, Qiang, et al.
Publicado: (2022)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
por: Huang, Dong, et al.
Publicado: (2021)

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials
por: Feng, Yujia, et al.
Publicado: (2022)

The effects of supervision on three different exercises modalities (supervised vs. home vs. supervised+home) in older adults: Randomized controlled trial protocol
por: Costa, Sabrine Nayara, et al.
Publicado: (2021)

Temporal trends in relative survival following percutaneous coronary intervention
por: Hulme, William J, et al.
Publicado: (2019)

Percutaneous repair of unroofed coronary sinus with an atrial septal occluder
por: Wang, Cheng, et al.
Publicado: (2023)

Case report: Constrictive pericarditis after coronary artery perforation during percutaneous coronary intervention
por: Kim, Kyung An, et al.
Publicado: (2023)

Feasibility and Safety of Chronic Total Occlusion Percutaneous Coronary Intervention via Distal Transradial Access
por: Lin, Cheng-Jui, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab
por: Jacquinot, Quentin, et al.
Publicado: (2022)

A Practical Approach to the Percutaneous Treatment of Iatrogenic Aorto-coronary Dissection
por: Kassimis, George, et al.
Publicado: (2018)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Percutaneous coronary intervention in a patient with homozygous RNF213 variant
por: Yashima, Fumiaki, et al.
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Hypothyroidism predicts worsened prognosis in patients undergoing percutaneous coronary intervention
por: Cohen, Ben, et al.
Publicado: (2022)

The role of intravascular imaging in chronic total occlusion percutaneous coronary intervention
por: Xenogiannis, Iosif, et al.
Publicado: (2023)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Physiological and psychological effects of a 12-week home-based telemonitored training in metabolic syndrome
por: Máthéné Köteles, Éva, et al.
Publicado: (2023)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Exercise and hypoxia unmask pulmonary vascular disease and right ventricular dysfunction in a 10‐ to 12‐week‐old swine model of neonatal oxidative injury
por: Steenhorst, Jarno J., et al.
Publicado: (2022)

Signaling and structures underpinning conducted vasodilation in human and porcine intramyocardial coronary arteries
por: Dora, Kim A., et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

A Novel Classification for Predicting Chronic Total Occlusion Percutaneous Coronary Intervention
por: Zhang, Dongfeng, et al.
Publicado: (2022)

The Role of Multimodality Imaging for Percutaneous Coronary Intervention in Patients With Chronic Total Occlusions
por: Melotti, Eleonora, et al.
Publicado: (2022)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Primary percutaneous coronary intervention for cardio-cerebral infarction: a case report
por: Watanabe, Tomomi, et al.
Publicado: (2023)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l197qo2ejmcbbui6tf4jig2v5q